Appendix B: Panel Roster and Financial Disclosures
Candidiasis
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Michail Lionakis* | National Institutes of Health | None | N/A |
| Michael Mansour | Massachusetts General Hospital | GenMark Diagnostics | Scientific Advisory Board |
|
Genetech Thermo Fisher Scientific |
Research Support (paid to institution) | ||
| Sorrento Therapeutics | Equity Interest | ||
|
Vericel Pulsethera NED Biosystems Day Zero Diagnostics Clear Creek Bio |
Consultant | ||
| Jeniel Nett | University of Wisconsin–Madison, School of Medicine and Public Health | None | N/A |
| Sanjay Revankar | Wayne State University School of Medicine | Merck | Consultant |
| Jack Sobel | Wayne State University School of Medicine | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section Only PDF (81.83 KB)|spaceless
- Full Guideline PDF (5.8 MB)|spaceless
- Tables Only PDF (1006.96 KB)|spaceless